Scalemic Stereogenic R-(N-Carbamoyl)alkylcuprates
N-[(1,1-Dim eth yleth oxy)car bon yl]-2-[2-(1-h exen yl)]pyr -
EI 273 (0.5, M+), 217 (23), 114 (100). Anal. Calcd for C17H23
NO2: C, 74.72; H, 8.42. Found: C, 74.71; H, 8.61.
-
r olid in e (16). [R]24 +28.8 (c 3.19, THF) for sample with er
D
97.8:2.2 by chiral HPLC; IR 2965, 2934, 2879, 1701, 1389,
Carbamate 22 (137 mg, 0.5 mmol) was dissolved in meth-
ylene chloride (10 mL), cooled to -78 °C, and then treated with
ozone for 5 min. When a slight blue color was observed, Me2S
(122 mg, 2.0 mmol) was added and stirring continued for 30
min while warming to room temperature. Then aqueous
NaHCO3 (5 mL) was added and the layers were separated.
The organic layer was dried (MgSO4) and concentrated in
vacuo to give a clear yellow oil that was purified by column
chromatography (Rf 0.40, petroleum ether/EtOAc, 80:20 (v/v))
to give the known ketone (2-benzoylpyrrolidine-1-carboxylic
1
1366, 1178, 1124, 878, 770 cm-1; H NMR δ 0.91 (t, J ) 7.5
Hz, 3 H), 1.17-1.64 (m, 13 H), 1.64-1.92 (m, 3 H), 1.92-2.39
(m, 3 H), 3.44 (br s, 2 H), 4.19 (4.28) (br s, 1 H), 4.71 (s, 1 H),
4.75 (s, 1H) (rotamer); 13C NMR δ 13.9, 22.6, 23.0, 28.4, 30.2,
31.3, 32.7, 46.5, 61.3, 78.9, 107.2, 150.2, 154.6; mass spectrum
m/z (rel intensity) EI 253 (0.5, M+), 197 (13), 180 (13), 154 (18),
144 (100), 83 (1). Anal. Calcd for C15H27NO2: C, 71.15; H,
10.67. Found: C, 70.87; H, 10.69.
N-[(1,1-Dim eth yleth oxy)ca r bon yl]-2-[1-(1-m eth ylid in e-
3-ter t-bu tyld im eth ylsilyloxy)p r op yl]p yr r olid in e (17). IR
(neat) 3068, 2948, 2880, 1709, 1649, 1470, 1384, 1247, 1162,
acid, tert-butyl ester)28c as a clear colorless oil (95%): [R]23
D
+28.1 (c 1.35, CHCl3); IR (neat) 2985 (m), 1703 (vs), 1411 (vs),
1170 (s), cm-1; 1H NMR (CDCl3) δ 1.23 (1.43) (2 s, 9H), 1.75-
2.05 (m, 3H), 2.25-2.40 (m, 1H), 3.35-3.75 (m, 2H), 5.14 (5.30)
(dd, J ) 3.7 Hz, J ) 5.0 Hz, 1H), 7.35-7.60 (m, 3H), 7.85-
8.00 (m, 2H) (rotamers); 13C NMR (CDCl3) δ 23.1 (24.1), 28.2
(28.4), (29.8) 30.8, 46.6, (46.8), (61.1) 61.3, (79.6) 79.7, 128.1,
128.7 133.2, 133.2, 135.3, 153.8, (198.4) 198.9 (rotamers); mass
spectrum, m/z (rel intensity) 275 (0.5, M+), 202 (10), 170 (48),
158 (12), 130 (6), 114 (91), 70 (100), 57 (82).
1
1102, 837, 760; H NMR δ 0.01 (s, 6H), 0.84 (s, 9H), 1.35 (s,
9H), 1.70-1.81 (m, 3H), 1.83-1.94 (m, 1H), 2.13-2.35 (m, 2H),
3.37-3.39 (m, 2H), 3.69-3.83 (m, 2H), 4.11-4.31 (m, 1H), 4.73
(s, 2H); 13C NMR δ 1.4, 18.2, 22.4 (22.7), 25.9, 28.4, 31.3 (31.0),
36.6 (36.3), 46.5 (46.3), 61.4, 62.5, 78.9, 108.9, 140.8 (140.7),
154.5 (rotamer); mass spectrum, m/z (rel intensity) EI 355 (0.4,
M+), 282 (12), 255 (12), 242 (64), 212 (39), 198 (51), 182 (21),
122 (35), 110 (97), 75 (44), 57 (100). Anal. Calcd for C19H37
NO3Si: C, 64.22; H, 10.42. Found: C, 64.39; H, 10.50.
-
N-[(1,1-Dim et h ylet h oxy)ca r b on yl]-2-[1-(1,2-p r op a d i-
en yl)]p yr r olid in e (23). IR (neat) 3068, 2974, 2880, 1948,
1-[(1,1-Dim eth yleth oxy)ca r bon yl]-2-[1-cycloh exen yl]-
1
1690, 1463, 1181, 1295, 1181, 1102, 844; H NMR δ 1.41 (s,
1
p yr r olid in e (18). IR (neat) 1695, 1629, 1454, 1395 cm-1; H
9H), 1.75-1.85 (m, 4H), 3.32 (br s, 2H), 4.28 (br s, 1H), 4.74-
4.77 (m, 2H), 5.17 (br s, 1H); 13C NMR δ 22.5 (23.6), 28.5, 32.3
(31.2), 45.8, 57.5, 77.2, 79.0, 93.0 (92.5), 154.5, 207.0 (rotamer);
mass spectrum, m/z (rel intensity) 170 (4), 153 (40), 136 (13),
114 (70), 70 (79), 57 (100). Anal. Calcd for C12H19NO2: C, 68.90;
H, 9.10; N, 6.70. Found: C, 69.01; H, 9.15; N, 6.72.
NMR δ 1.21-2.00 (m, 21H), 3.21-3.50 (m, 2H), 3.84-4.24 (m,
1H), 3.32 (s, 1H); 13C NMR δ 22.6, 23.1, 24.7, 28.3, 31.2, 46.6,
61.3, 62.5, 78.6, 120.0, 137.5, 155.0; mass spectrum, EI, m/z
251(0.5, M+), 195 (44), 178 (9), 114 (100). Anal. Calcd for
C15H25NO2: C, 71.73; H, 9.95. Found: C, 71.75; H, 10.08.
N-[(1,1-Dim eth yleth oxy)ca r bon yl]-2-(3-oxo-1-cycloh ex-
N-[(1,1-Dim et h ylet h oxy)ca r b on yl]-2-[1-[1-(3-p h en yl-
p r op yl)-1,2-p r op a d ien yl]]p yr r olid in e (24). IR (neat) 3017,
2969, 2921, 2872, 1963, 1689, 1439, 1391, 1359, 1254, 1166,
1109, 844; 1H NMR δ 1.41 (s, 9H), 1.74-1.92 (m, 8H), 2.63 (t,
J ) 7.4 Hz, 2H), 3.29-3.35 (m, 2H), 4.12-4.21 (m, 1H), 4.71-
4.76 (m, 2H), 7.14-7.26 (m, 5H); 13C NMR δ 22.6 (23.2), 28.4,
28.6 (3C), 29.2, 30.2 (31.2), 35.4, 45.9, 58.9 (58.7), 78.2, 78.7,
106.2 (105.8), 125.5, 128.1, 128.3, 142.1, 154.2, 204.4 (rotamer);
mass spectrum, m/z (rel intensity) 271 (28), 254 (5), 167 (37),
114 (100), 91 (32), 70 (91), 57 (94), 41 (45), 29 (16).
1
en yl)p yr r olid in e (20). H NMR δ 1.27-1.34 (m, 9H), 1.64-
1.78 (m, 3H), 1.85-2.30 (m, 7H), 3.31-3.43 (m, 2H), 4.15-
4.28 (m, 1H), 5.76 (s, 1H); 13C NMR δ 22.6 (23.2), 26.1 (26.6),
28.2, 30.4, 31.8, 37.5, 46.7, 61.8 (61.3), 79.5, 123.6 (123.1),
154.5, 166.7 (166.1), 199.3 (rotamer); mass spectrum, m/z (rel
intensity) EI 266 (1, M+ + 1), 209 (50), 192 (23), 164 (18), 137
(44), 114 (46), 70 (51), 57 (100).
1-[(1,1-Dim et h ylet h oxy)ca r b on yl]-2-[1-(1,1-d im et h yl-
eth yl)eth en yl]p yr r olid in e (21). [R]24 +39.9 (c 2.68, THF)
D
for sample with er 89.5:10.5 by HPLC; IR (neat) 1697, 1652,
1476, 1392, cm-1; NMR δ 1.08 (s, 9H), 1.37 (s, 9H), 1.55-2.60
(m, 4H), 3.21-3.54 (m, 2H), 4.29-4.47 (s, 1H), 4.64-4.82 (s,
1H); 13C NMR δ 21.9, 28.6, 30.4, 30.6, 33.1, 35.0, 46.9, 57.8,
78.7, 105.6, 158.7; mass spectrum, m/z (rel intensity) EI 253
(0.5, M+), 197 (14), 114 (100). Anal. Calcd for C15H27NO2: C,
71.14; H, 10.67. Found: C, 70.72; H, 10.88.
N-[(1,1-Dim et h ylet h oxy)ca r b on yl]-2-[1-(1-p h en yl-1,2-
p r op a d ien yl)]p yr r olid in e (25). IR (neat) 3051, 2972, 2884,
1944, 1689, 1442, 1386, 1243, 1171, 1115, 1075, 868, 797; H
NMR δ 1.38-1.44 (m, 9H), 1.77-2.09 (m, 4H), 3.30-3.48 (m,
2H), 4.75-4.91 (m, 1H), 5.03-5.16 (m, 2H), 7.09-7.41 (m, 5H);
13C NMR 22.5 (23.5), 28.4, (30.9) 32.0, 45.9 (46.2), 57.3 (57.0),
80.1, 78.9, 109.4 (108.3), 126.8, 126.4, 128.4, 135.2 (134.7),
154.3, 207.0 (rotamer); mass spectrum, m/z (rel intensity) 281
(2), 229 (77), 212 (13), 184 (28), 114 (100), 89 (16), 70 (78), 57
(89).
1
1-[(1,1-Dim eth yleth oxy)ca r bon yl]-2-[1-p h en yleth en yl]-
p yr r olid in e (22). N-Boc pyrrolidine (12, 171 mg, 1.0 mmol)
was dissolved in freshly distilled Et2O (3.0 mL) along with (-)-
sparteine (234 mg, 1.0 mmol). The reaction mixture was cooled
to -78 °C under an argon atmosphere and s-BuLi (1.0 mL,
1.0 mmol) was added dropwise by syringe. The resultant
solution was stirred at -78 °C for 1 h. Then a solution
containing CuCN (90 mg, 1.0 mmol) and LiCl (90 mg, 2.0
mmol) in THF (3.0 mL) was added dropwise by syringe. The
mixture was allowed to stir at -78 °C for 30 min before the
addition of enol triflate 7b (252 mg, 1.0 mmol). The reaction
mixture was allowed to warm quickly to -50 °C and then
slowly to room temperature overnight. The reaction mixture
was diluted with Et2O (20 mL) and quenched with HCl (5%
aqueous, 15 mL). Upon separation of the layers, the organic
layer was dried (MgSO4) and concentrated in vacuo to give an
oil that was purified by column chromatography (Rf 0.25,
petroleum ether/Et2O, 85:15, v/v) affording 22 as a clear
N-[(1,1-Dim et h ylet h oxy)ca r b on yl]-2-(2-p r op en -1-yl)-
p yr r olid in e (26). [R]24 +38.0 (c 3.69, THF) for sample with
D
er 89.0:11.0 by HPLC [lit.28b [R]25 -32.4 (c 1.56, CHCl3)]; IR
D
1
(neat) 1696, 1645, 1365, 1252 cm-1; H NMR δ 1.41 (s, 9H),
1.54-1.84 (m, 4H), 2.00-2.20 (m, 1H), 2.32-2.54 (m, 1H),
3.14-3.40 (m, 2H), 3.61-3.80 (m, 1H), 4.91-5.12 (m, 2H),
5.58-5.72 (m, 1H); 13C NMR δ 23.1, 28.5, 30.0, 28.1, 45.6, 53.7,
78.8, 116.9, 135.2, 145.0; mass spectrum, m/z (rel intensity)
EI 170 (6.4), 114 (54), 70 (100).
5-P h en yl-5-[[(1,1-dim eth yleth oxy)car bon yl]eth ylam in o]-
p en ta n -2-on e (31). 1H NMR δ 0.80-0.95 (m, 3H), 1.56 (s, 9H),
2.22 (s, 3H), 2.23-2.40 (m, 2H), 2.52-2.70 (m, 2H), 2.92-3.10
(m, 2H), 5.20-5.45 (m, 1H), 7.25-7.42 (m, 5H); 13C NMR δ
15.0, 24.5, 28.5, 30.1, 38.1, 40.4, 56.3, 78.9, 127.3, 127.7, 128.3,
140.5, 156.3, 208.1; mass spectrum, m/z (rel intensity) EI 305
(0.5, M+), 249 (22), 204 (7), 178 (42); high-resolution mass
spectrum m/z 305.1997 (M+) (calcd for C18H27NO3 305.1991).
1-[(1,1-Dim eth yleth oxy)ca r bon yl]eth yl[(E)-1-p h en yl-2-
h ep ten yl]a m in e (33). IR (neat) 2961, 2930, 2868, 1683, 1443,
colorless oil (56%, 91% ee): IR (neat) 1697, 1623, 1558, 1446,
1
1394 cm-1
;
H NMR δ 1.50 (1.56) (s, 9H), 1.66-2.16 (m, 4H),
3.42-3.71 (m, 2H), 4.82 (d, J ) 8.0 Hz, 1H), 4.92 (d, J ) 8.0
Hz, 1H), 5.05 (s, 1H), 5.27 (5.30) (s, 1H), 7.30-7.41 (m, 5H);
13C NMR δ 22.2, 28.4, 31.5, 46.5, 60.6, 79.2, 110.8, 126.7, 127.4,
128.3, 140.1, 150.0, 154.4; mass spectrum, m/z (rel intensity)
1
1412, 1381, 1272, 1164, 963, 877 cm-1; H NMR δ 0.97-1.13
(m, 6H), 1.34-1.66 (m, 14H), 2.17-2.24 (m, 2H), 3.09-3.30
J . Org. Chem, Vol. 69, No. 9, 2004 3085